Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01YGD
|
||||
| Former ID |
DIB008118
|
||||
| Drug Name |
ICO-25
|
||||
| Synonyms |
Imuteran; Anti-MUC1 monoclonal antibodies, P Hertzen Moscow Cancer Research Institute; Anti-AG-4 antibodies, P Hertzen Moscow Cancer Research Institute
|
||||
| Drug Type |
Antibody
|
||||
| Indication | Breast cancer [ICD9: 174, 175; ICD10:C50] | Phase 2 | [528859] | ||
| Company |
Russian National Cancer Research Center
|
||||
| Target and Pathway | |||||
| Target(s) | Mucin 1 | Target Info | [526513] | ||
| WikiPathways | Hematopoietic Stem Cell Differentiation | ||||
| References | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.

